Psychometric validation of the revised SCOPA-Diary Card: Expanding the measurement of non-motor symptoms in parkinson's disease

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Rendas Baum, Regina ^a   Buck, Philip O ^b   White, Michelle K ^a   Castelli Haley, Jane ^b  

^a QualityMetric Incorporated   (United States)

^b Teva Neuroscience Inc   (United States)

Author keywords

Diary; Non motor symptoms; Parkinson's disease; Quality of life; Reliability; SCOPA; Validity

Indexed keywords

AGED; ANXIETY; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; COGNITIVE DEFECT; DYSPHAGIA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PANIC; PARKINSON DISEASE; PSYCHOMETRY; QUALITY OF LIFE INDEX; RATING SCALE; RELIABILITY; SCALES FOR OUTCOMES OF PARKINSON DISEASE DIARY CARD; SCORING SYSTEM; UNITED STATES; URINE INCONTINENCE; VALIDATION STUDY; CROSS-SECTIONAL STUDY; FACTORIAL ANALYSIS; INFORMATION PROCESSING; MEDICAL RECORD; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; REPRODUCIBILITY; STANDARD; STATISTICAL MODEL; TIME;

DOPAMINE RECEPTOR STIMULATING AGENT;

CROSS-SECTIONAL STUDIES; DOPAMINE AGENTS; FACTOR ANALYSIS, STATISTICAL; FOCUS GROUPS; HUMANS; LOGISTIC MODELS; MEDICAL RECORDS; PARKINSON DISEASE; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; TIME FACTORS; UNITED STATES;

EID: 80051795335     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-69     Document Type: Article

References (46)

1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006, 5(6):525-535. 10.1016/S1474-4422(06)70471-9, 16713924.
2. Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Engl J Med 2003, 348(14):1356-1364. 10.1056/NEJM2003ra020003, 12672864.
3. Adler CH. Nonmotor complications in Parkinson's disease. Mov Disord 2005, 20(Suppl 11):S23-S29.
4. Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, MacPhee G, Kelly L, Rabey M, MacMahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006, 21(7):916-923. 10.1002/mds.20844, 16547944.
5. Cheon SM, Ha MS, Park MJ, Kim JW. Nonmotor symptoms of Parkinson's disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord 2008, 14(4):286-290. 10.1016/j.parkreldis.2007.09.002, 18042421.
6. Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007, 22(11):1623-1629. 10.1002/mds.21586, 17546669.
7. Simuni T, Sethi K. Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008, 64(Suppl 2):S65-S80.
8. Snyder CH, Adler CH. The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms. J Am Acad Nurse Pract 2007, 19(4):179-197. 10.1111/j.1745-7599.2007.00211.x, 17430539.
9. Zesiewicz TA, Sullivan KL, Hauser RA. Nonmotor symptoms of Parkinson's disease. Expert Rev Neurother 2006, 6(12):1811-1822. 10.1586/14737175.6.12.1811, 17181428.
10. Gallagher DA, Schrag A. Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease. CNS Drugs 2008, 22(7):563-586. 10.2165/00023210-200822070-00003, 18547126.
11. Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ. Clinical features and comorbidity of mood fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002, 14(4):438-442. 10.1176/appi.neuropsych.14.4.438, 12426412.
12. Buck PO, Trautman H, Clark J. Scales for assessing nonmotor symptom severity changes in Parkinson's disease patients with symptom fluctuations. International Journal of Neuroscience 2010, 120(8):523-530. 10.3109/00207454.2010.489725, 20615055.
13. Quinn NP. Classification of fluctuations in patients with Parkinson's disease. Neurology 1998, 51(2 Suppl 2):S25-S29.
14. Hou JG, Lai EC. Overview of Parkinson's disease: clinical features, diagnosis, and management. Neurorehabilitation in Parkinson's Disease: An Evidence Based Treatment Model 2008, 1-40. NJ: Slack Incorporated, Trail M, Protas EJ, Lai EC.
15. Brooks DJ, Agid Y, Eggert K, Widner H, Ostergaard K, Holopainen A. Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment. Eur Neurol 2005, 53(4):197-202. 10.1159/000086479, 15970632.
16. Trail M, Protas EJ, Lai EC. Neurorehabilitation in Parkinson's Disease: An Evidence Based Treatment Model. 2008, NJ: Slack Incorporated.
17. Stacy M, Hauser R, Oertel W, Schapira A, Sethi K, Stocchi F, Tolosa E. End-of-dose wearing off in Parkinson disease: a 9-question survey assessment. Clin Neuropharmacol 2006, 29(9):312-321.
18. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, MacPhee G, MacMahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord 2007, 22(13):1901-1911. 10.1002/mds.21596, 17674410.
19. Pursiainen V, Haapaniemi TH, Korpelainen JT, Sotaniemi KA, Myllyla VV. Sweating in Parkinsonian patients with wearing-off. Mov Disord 2007, 22(6):828-832. 10.1002/mds.21422, 17357129.
20. Witjas T, Kaphan E, Regis J, Jouve E, Cherif AA, Peragut JC, Azulay JP. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007, 22(12):1729-1734. 10.1002/mds.21602, 17557355.
21. Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, Poncet M, Cherif AA. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002, 59(3):408-413.
22. Marinus J, Visser M, Stiggelbout AM, Rabey JM, Bonuccelli U, Kraus PH, van Hilten JJ. Activity-based diary for Parkinson's disease. Clin Neuropharmacol 2002, 25(1):43-50. 10.1097/00002826-200201000-00008, 11852296.
23. Strauss A, Corbin J. Grounded Theory Methodology: an overview. Strategies of Qualitative Inquiry 2003, 273-285. London: Sage, Denzin N, Lincoln Y.
24. KnowledgePanel® Design Summary. Knowledge Networks. 2010, http://www.knowledgenetworks.com/knpanel/KNPanel-Design-Summary.html
25. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to Score Version 2 of the SF-12® Health Survey (With a Supplement Documenting Version 1). 2002, RI: QualityMetric Incorporated.
26. Kosinski M, Bjorner JB. Evaluation of the validity of BDI scores estimated from the SF-36 mental health scale. Quality of Life Research 2009, 1416:A24.
27. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psycho Health 1997, 12:805-814.
28. Stacy MA, Murphy JM, Greeley DR, Stewart RM, Murck H, Meng X. The sensitivity and specificity of the 9-item Wearing-off Questionnaire. Parkinsonism Relat Disord 2008, 14(3):205-212. 10.1016/j.parkreldis.2007.07.013, 17900967.
29. Burman PA. A comparative study of ordinary cross validation, k fold cross validation and repeated learning tested methods. Biometrika 1989, 503-514.
30. Muthen B. Tobit factor analysis. British Journal of Mathematical and Statistical Psychology 1989, 42:241-250.
31. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling 1999, 6:1-55.
32. Brown T. Confirmatory Factor Analysis for Applied Research 2006, New York: The Guilford Press.
33. Hendrickson AE, White PO. Promax: A quick method for rotation to oblique simple structure. British Journal of Mathematical and Statistical Psychology 1964, 17:65-70.
34. Muthen LD, Muthen BO. MPlus User's Guide 2007, CA: Muthen & Muthen, 5.
35. Nunnally JC, Bernstein IH. Psychometric Theory 1994, New York: McGraw-Hill, 3.
36. Clark LA, Watson D. Constructing validity: Basic issues in objective scale development. Psychological Assessment 1995, 7(3):309-319.
37. Kerlinger F. Foundations of Behavioral Research 1973, New York: Holt, Rinehart & Winston.
38. Diggle P, Heagerty P, Liang K. Analysis of Longitudinal Data 2002, Oxford: University Press, second.
39. Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ. A comprehensive model of health-related quality of life in Parkinson's disease. J Neurol 2008, 255(10):1580-1587. 10.1007/s00415-008-0994-4, 18821041.
40. Visser M, Verbaan D, van Rooden S, Marinus J, van Hilten J, Stiggelbout A. A Longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health 2009, 12(2):392-396. 10.1111/j.1524-4733.2008.00430.x, 18657099.
41. Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G. Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 2008, 23(10):1420-1427. 10.1002/mds.22121, 18512757.
42. Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Kohne-Volland R, Dodel RC. Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study. Parkinsonism Relat Disord 2007, 13(2):108-114. 10.1016/j.parkreldis.2006.07.009, 17055326.
43. Jackson DL. Sample Size and number of parameter estimates in Maximum Likelihood Conformatory Factor Analysis: a Monte Carlo investigation. Structural Equation Modeling 2001, 8(2):205-223.
44. Park A, Stacy M. Non-motor symptoms in Parkinson's disease. J Neurol 2009, 256(Suppl 3):293-298.
45. Lee MA, Walker RW, Hildreth AJ, Prentice WM. Individualized assessment of quality of life in idiopathic Parkinson's disease. Mov Disord 2006, 21(11):1929-1934. 10.1002/mds.21099, 16986143.
46. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008, 23(15):2129-2170. 10.1002/mds.22340, 19025984.